Delivery Order SPE2DB20D1102-SPE2DB25FC6SW
- Not listed
- The Defense Logistics Agency awarded a $1,066.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count units). This non-competitive, non-set-aside delivery order is scheduled for completion by July 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a $1,858.83 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count unit). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,533.09 to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) on August 7, 2025, with completion targeted for August 8, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count units) under a firm fixed-price contract valued at $51,984.29. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract award was not set aside and was competitively awarded,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count) with a ceiling value of $1,199.22. This contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for ultimate completion by July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,197,360 units of esomeprazole magnesium delayed-release 40 mg capsules. The $2,697.71 firm-fixed price delivery order has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,177.12 firm fixed-price delivery order is for the supply of Esomeprazole Magnesium Delayed-Release Capsules, 40 mg, in quantities of 30. The contract has an ultimate completion date of July 18, 2025 and was not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,158,716 units of the medication Esomeprazole Magnesium Delayed-Release 40 mg Capsules. The award has a ceiling value of $2,439.58 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6SWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,942.94 to AmerisourceBergen Drug Corp for the supply of esomeprazole magnesium delayed-release 40 mg capsules (30-count units). This order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The parent IDC enables the company to supply a broad range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/31/25 |